Stay updated on Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial
Sign up to get notified when there's something new on the Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial page.

Latest updates to the Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page's revision tag was updated to v3.5.4, replacing the previous v3.5.3 and signaling a new release version.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page’s footer revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site software update without changing the study information shown.SummaryDifference0.0%

- Check41 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check55 days agoChange DetectedAdded a related topic entry for hereditary factor VIII deficiency disease and the Genetic and Rare Diseases Information Center resources.SummaryDifference0.1%

- Check62 days agoChange DetectedRemoved the Hemophilia A reference and the Genetic and Rare Diseases Information Center resource from the page.SummaryDifference0.1%

- Check70 days agoChange DetectedSite template revision updated from version v3.4.3 to v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial page.